Login / Signup

A Novel Insight into the Immune-Related Interaction of Inflammatory Cytokines in Benign Prostatic Hyperplasia.

Xiaokaiti NaiyilaJinze LiYin HuangBo ChenMengli ZhuJin LiZeyu ChenLu YangJianzhong AiQiang WeiLiangren LiuDehong Cao
Published in: Journal of clinical medicine (2023)
Benign prostatic hyperplasia (BPH) is a common male condition that impacts many men's quality of life by generating lower urinary tract symptoms (LUTS). In recent years, inflammation has become very common in the prostate, and BPH with inflammation has a higher International Prostate Symptom Score (IPSS) score and an enlarged prostate. Chronic inflammation leads to tissue damage and the release of pro-inflammatory cytokines, which play an important role in the pathogenesis of BPH. We will focus on current advancements in pro-inflammatory cytokines in BPH, as well as the future of pro-inflammatory cytokine research.
Keyphrases
  • benign prostatic hyperplasia
  • lower urinary tract symptoms
  • oxidative stress
  • prostate cancer
  • current status
  • drug induced
  • patient reported